BR112018008359B1 - Sistema adaptado para tratamento térmico de tecidos biológicos - Google Patents
Sistema adaptado para tratamento térmico de tecidos biológicos Download PDFInfo
- Publication number
- BR112018008359B1 BR112018008359B1 BR112018008359-3A BR112018008359A BR112018008359B1 BR 112018008359 B1 BR112018008359 B1 BR 112018008359B1 BR 112018008359 A BR112018008359 A BR 112018008359A BR 112018008359 B1 BR112018008359 B1 BR 112018008359B1
- Authority
- BR
- Brazil
- Prior art keywords
- approximately
- tissue
- pulsed
- target tissue
- energy source
- Prior art date
Links
- 238000010438 heat treatment Methods 0.000 title description 15
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims abstract description 76
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims abstract description 76
- 230000004913 activation Effects 0.000 claims abstract description 36
- 230000006378 damage Effects 0.000 claims abstract description 22
- 238000007669 thermal treatment Methods 0.000 claims abstract description 4
- 238000002604 ultrasonography Methods 0.000 claims description 64
- 230000036770 blood supply Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 22
- 230000001225 therapeutic effect Effects 0.000 abstract description 14
- 230000004044 response Effects 0.000 abstract description 6
- 230000035939 shock Effects 0.000 abstract description 5
- 230000002035 prolonged effect Effects 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 description 174
- 238000011282 treatment Methods 0.000 description 50
- 230000003287 optical effect Effects 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 24
- 238000010521 absorption reaction Methods 0.000 description 22
- 230000005855 radiation Effects 0.000 description 19
- 230000008901 benefit Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- 230000005670 electromagnetic radiation Effects 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 230000002207 retinal effect Effects 0.000 description 14
- 230000005451 protein repair Effects 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 238000009792 diffusion process Methods 0.000 description 11
- 210000000624 ear auricle Anatomy 0.000 description 11
- 230000008439 repair process Effects 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000006870 function Effects 0.000 description 9
- 239000002775 capsule Substances 0.000 description 8
- 230000035515 penetration Effects 0.000 description 8
- 230000000638 stimulation Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 239000013307 optical fiber Substances 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- 210000001525 retina Anatomy 0.000 description 5
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000000451 tissue damage Effects 0.000 description 5
- 231100000827 tissue damage Toxicity 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 206010012689 Diabetic retinopathy Diseases 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 206010064930 age-related macular degeneration Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000002780 macular degeneration Diseases 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 210000003928 nasal cavity Anatomy 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 101100507655 Canis lupus familiaris HSPA1 gene Proteins 0.000 description 3
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000003915 cell function Effects 0.000 description 3
- 201000011190 diabetic macular edema Diseases 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000014951 hematologic disease Diseases 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000013532 laser treatment Methods 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 201000007914 proliferative diabetic retinopathy Diseases 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 230000004304 visual acuity Effects 0.000 description 3
- 208000019838 Blood disease Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010049816 Muscle tightness Diseases 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 210000000746 body region Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 238000002052 colonoscopy Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003818 metabolic dysfunction Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000001989 nasopharynx Anatomy 0.000 description 2
- 231100001160 nonlethal Toxicity 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000000649 photocoagulation Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000001533 respiratory mucosa Anatomy 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 description 1
- 101710154868 60 kDa heat shock protein, mitochondrial Proteins 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010071155 Autoimmune arthritis Diseases 0.000 description 1
- 101100339887 Drosophila melanogaster Hsp27 gene Proteins 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 102000003676 Glucocorticoid Receptors Human genes 0.000 description 1
- 108090000079 Glucocorticoid Receptors Proteins 0.000 description 1
- 102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 description 1
- 108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 description 1
- 101150096895 HSPB1 gene Proteins 0.000 description 1
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 description 1
- 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 208000001344 Macular Edema Diseases 0.000 description 1
- 206010025415 Macular oedema Diseases 0.000 description 1
- 206010064912 Malignant transformation Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 206010057430 Retinal injury Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000007960 cellular response to stress Effects 0.000 description 1
- 230000004637 cellular stress Effects 0.000 description 1
- 201000005667 central retinal vein occlusion Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 201000008615 cone dystrophy Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000002839 fiber optic waveguide Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000000266 injurious effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000010230 macular retinal edema Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036212 malign transformation Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 231100001049 no known adverse-effect Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 238000010248 power generation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 230000006432 protein unfolding Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/02—Radiation therapy using microwaves
- A61N5/022—Apparatus adapted for a specific treatment
- A61N5/025—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/02—Radiation therapy using microwaves
- A61N5/04—Radiators for near-field treatment
- A61N5/045—Radiators for near-field treatment specially adapted for treatment inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
- A61N7/022—Localised ultrasound hyperthermia intracavitary
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0604—Lungs and/or airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0608—Rectum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0609—Stomach and/or esophagus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/063—Radiation therapy using light comprising light transmitting means, e.g. optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0073—Ultrasound therapy using multiple frequencies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0082—Scanning transducers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Radiation-Therapy Devices (AREA)
- Endoscopes (AREA)
- Laser Surgery Devices (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Surgical Instruments (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/922,885 | 2015-10-26 | ||
| US14/922,885 US9427602B2 (en) | 2012-05-25 | 2015-10-26 | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair |
| US15/214,726 US10531908B2 (en) | 2012-05-25 | 2016-07-20 | Method for heat treating biological tissues using pulsed energy sources |
| US15/214,726 | 2016-07-20 | ||
| PCT/US2016/046043 WO2017074532A1 (en) | 2015-10-26 | 2016-08-08 | Method for heat treating biological tissues using pulsed energy sources |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112018008359A2 BR112018008359A2 (pt) | 2018-10-23 |
| BR112018008359B1 true BR112018008359B1 (pt) | 2022-10-18 |
Family
ID=58631061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018008359-3A BR112018008359B1 (pt) | 2015-10-26 | 2016-08-08 | Sistema adaptado para tratamento térmico de tecidos biológicos |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3368153A4 (enExample) |
| JP (4) | JP7125117B2 (enExample) |
| CN (1) | CN108136195A (enExample) |
| AU (2) | AU2016346526B2 (enExample) |
| BR (1) | BR112018008359B1 (enExample) |
| CA (1) | CA2996981C (enExample) |
| HK (1) | HK1252432A1 (enExample) |
| SG (1) | SG11201801331UA (enExample) |
| WO (1) | WO2017074532A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL260382B2 (en) * | 2016-02-13 | 2023-04-01 | Lumenis Ltd | Device and cosmetic method to treat excessive sweating |
| GB2587031A (en) * | 2019-09-16 | 2021-03-17 | Creo Medical Ltd | Electrosurgical apparatus for treating biological tissue with microwave energy, and method for controlling microwave energy |
| KR102355947B1 (ko) * | 2021-03-23 | 2022-02-08 | 어썸레이 주식회사 | 전자기파를 이용한 염증성 질환의 치료, 억제 및 예방을 위한 치료 장치 및 방법 |
| CN114818412B (zh) * | 2022-03-18 | 2022-09-27 | 北京航空航天大学 | 一种人脑受电磁辐射的高精度计算方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4825880A (en) * | 1987-06-19 | 1989-05-02 | The Regents Of The University Of California | Implantable helical coil microwave antenna |
| JPH01135367A (ja) * | 1987-11-20 | 1989-05-29 | Olympus Optical Co Ltd | レーザ光照射装置 |
| JPH02252469A (ja) * | 1989-03-27 | 1990-10-11 | Olympus Optical Co Ltd | 生体深部治療装置 |
| US6156028A (en) * | 1994-03-21 | 2000-12-05 | Prescott; Marvin A. | Method and apparatus for therapeutic laser treatment of wounds |
| US5983141A (en) * | 1996-06-27 | 1999-11-09 | Radionics, Inc. | Method and apparatus for altering neural tissue function |
| DE19823947A1 (de) * | 1998-05-28 | 1999-12-02 | Baasel Carl Lasertech | Verfahren und Vorrichtung zum oberflächlichen Erwärmen von Gewebe |
| US6640139B1 (en) * | 1998-10-20 | 2003-10-28 | Dornier Medtech Holding International Gmbh | Thermal therapy with tissue protection |
| US20020091377A1 (en) | 2000-01-25 | 2002-07-11 | Anderson R. Rox | Method and apparatus for medical treatment utilizing long duration electromagnetic radiation |
| JP2006500972A (ja) * | 2002-06-19 | 2006-01-12 | パロマー・メディカル・テクノロジーズ・インコーポレイテッド | ある深さの組織を輻射熱によって治療する方法および装置 |
| WO2004033040A1 (en) * | 2002-10-07 | 2004-04-22 | Palomar Medical Technologies, Inc. | Apparatus for performing photobiostimulation |
| US20040202663A1 (en) | 2003-01-28 | 2004-10-14 | Shanghai Sunway Biotech Co., Ltd. | Therapy for primary and metastatic cancers |
| JP2005087282A (ja) | 2003-09-12 | 2005-04-07 | Matsushita Electric Ind Co Ltd | レーザ治療装置 |
| JP2005224505A (ja) | 2004-02-16 | 2005-08-25 | Terumo Corp | 光照射装置 |
| BRPI0509744A (pt) | 2004-04-09 | 2007-09-25 | Palomar Medical Tech Inc | métodos e produtos para produção de látices de ilhotas tratadas com emr em tecidos e seus usos |
| AU2006272586A1 (en) | 2005-07-27 | 2007-02-01 | University Of Florida Research Foundation, Inc. | Use of heat shock to treat ocular disease |
| KR20090034925A (ko) * | 2006-06-27 | 2009-04-08 | 팔로마 메디칼 테크놀로지스, 인코포레이티드 | 핸드헬드 광미용 장치 |
| WO2008024795A2 (en) * | 2006-08-22 | 2008-02-28 | Schwartz Donald N | Ultrasonic treatment of glaucoma |
| US20080076958A1 (en) * | 2006-09-21 | 2008-03-27 | Alma Lasers Ltd. | Method And Apparatus For Treating A Fungal Nail Infection With Shortwave And/Or Microwave Radiation |
| ES2560006T3 (es) * | 2006-10-18 | 2016-02-17 | Vessix Vascular, Inc. | Inducción de efectos de temperatura deseables sobre tejido corporal |
| US9403029B2 (en) * | 2007-07-18 | 2016-08-02 | Visualase, Inc. | Systems and methods for thermal therapy |
| WO2009088550A2 (en) * | 2007-10-19 | 2009-07-16 | Lockheed Martin Corporation | System and method for conditioning animal tissue using laser light |
| US8174267B2 (en) * | 2008-09-30 | 2012-05-08 | Vivant Medical, Inc. | Intermittent microwave energy delivery system |
| US8141557B2 (en) * | 2008-10-22 | 2012-03-27 | Peyman Gholam A | Method of oscillatory thermotherapy of biological tissue |
| CA2786262A1 (en) * | 2010-01-07 | 2011-07-14 | Cheetah Omni, Llc | Fiber lasers and mid-infrared light sources in methods and systems for selective biological tissue processing and spectroscopy |
| JP5664996B2 (ja) * | 2010-03-29 | 2015-02-04 | 国立大学法人秋田大学 | 超音波照射装置 |
| US10219947B2 (en) | 2012-05-25 | 2019-03-05 | Ojai Retinal Technology, Llc | System and process for retina phototherapy |
| WO2014040015A1 (en) * | 2012-09-10 | 2014-03-13 | Dermal Photonics Corporation | Systems and methods for treating dermatological imperfections |
| WO2014070699A1 (en) * | 2012-11-01 | 2014-05-08 | Seminex Corporation | Variable intensity laser treatments of the skin |
-
2016
- 2016-08-08 JP JP2018507578A patent/JP7125117B2/ja active Active
- 2016-08-08 BR BR112018008359-3A patent/BR112018008359B1/pt active IP Right Grant
- 2016-08-08 HK HK18111733.9A patent/HK1252432A1/zh unknown
- 2016-08-08 SG SG11201801331UA patent/SG11201801331UA/en unknown
- 2016-08-08 EP EP16860435.3A patent/EP3368153A4/en not_active Withdrawn
- 2016-08-08 CN CN201680055265.9A patent/CN108136195A/zh active Pending
- 2016-08-08 AU AU2016346526A patent/AU2016346526B2/en active Active
- 2016-08-08 CA CA2996981A patent/CA2996981C/en active Active
- 2016-08-08 WO PCT/US2016/046043 patent/WO2017074532A1/en not_active Ceased
-
2020
- 2020-08-07 AU AU2020213374A patent/AU2020213374B2/en active Active
-
2022
- 2022-05-13 JP JP2022079632A patent/JP2022119821A/ja active Pending
- 2022-05-13 JP JP2022079631A patent/JP2022124488A/ja active Pending
- 2022-05-13 JP JP2022079630A patent/JP7353671B6/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2996981C (en) | 2023-08-01 |
| CN108136195A (zh) | 2018-06-08 |
| JP2022124488A (ja) | 2022-08-25 |
| JP2022119821A (ja) | 2022-08-17 |
| CA2996981A1 (en) | 2017-05-04 |
| AU2020213374B2 (en) | 2021-04-29 |
| EP3368153A1 (en) | 2018-09-05 |
| JP7353671B2 (ja) | 2023-10-02 |
| JP7125117B2 (ja) | 2022-08-24 |
| JP2022122878A (ja) | 2022-08-23 |
| AU2016346526B2 (en) | 2020-08-27 |
| WO2017074532A1 (en) | 2017-05-04 |
| BR112018008359A2 (pt) | 2018-10-23 |
| AU2016346526A1 (en) | 2018-03-15 |
| JP2018533992A (ja) | 2018-11-22 |
| SG11201801331UA (en) | 2018-05-30 |
| HK1252432A1 (zh) | 2019-05-24 |
| AU2020213374A1 (en) | 2020-08-27 |
| JP7353671B6 (ja) | 2023-10-20 |
| EP3368153A4 (en) | 2019-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10953241B2 (en) | Process for providing protective therapy for biological tissues or fluids | |
| US9427602B2 (en) | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair | |
| US10531908B2 (en) | Method for heat treating biological tissues using pulsed energy sources | |
| US20170203132A1 (en) | System and process utilizing pulsed energy to treat biological tissue | |
| JP6778772B2 (ja) | 標的とされた熱ショックタンパク質を刺激する及びタンパク質修復を促進するためのパルス状の電磁療法および超音波治療法 | |
| JP7353671B6 (ja) | レーザー光を利用し熱ショックタンパク質の活性化を刺激するように適応させたシステム | |
| JP2022119821A5 (enExample) | ||
| BR112019017891A2 (pt) | Processo para tratamento térmico de tecido biológico | |
| CA3030483A1 (en) | Process for providing protective therapy for biological tissues or fluids | |
| HK1237234B (zh) | 用於刺激靶向热休克蛋白以及促进蛋白质修复的脉冲电磁和超声疗法 | |
| HK1237234A1 (en) | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair | |
| WO2018169560A1 (en) | System and process utilizing pulsed energy to treat biological tissue | |
| HK1262194A1 (en) | Process for providing protective therapy for biological tissues or fluids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/08/2016, OBSERVADAS AS CONDICOES LEGAIS |